3Dwight T, Nelso AE, Marsh DJ, et al. Parathyroid tumorigenesis in association with primary hyperparathyroidism. Curr Opin Endocrinol Diabetes, 2002,9:51-60.
4Toni R. Prezant, Melmed S. Molecular pathogenesis of pituitary disorders. Curr Opin Endocrinol Diabetes, 2002,9:61-78.
5Sizemore GW. Multiple endocrine neoplasia. In Backer K (ed), Principles and practice of Endocrinology and Metabolism, 3rd ed. Philadelphia Baltimore: Lippincotts Wilkins & Williams, 2001.1696-1706.
6Larsson C, Skogeid B, Oberg K, etal. Multiple endocrine neoplasia type Ⅰgene maps to chromosome 11 and is lost ininsulinoma.Nature，1988,3 32:85-87.
7Kishi M.A novel splicing mutation (894-9 G-→A) of the MEN1 gene responsible formultiple endocrine neoplasia type 1. Cancer Lett，1999,142:105-110.
8Barbara P, Isabella C, Giovanni R. RET mutation in human disease.TrendsGenet.1996,12:138-142.
9Mulligan L M, Marsh D J, Robinson B G, et al.Genotype-phnotype correlation in MEN2:report of the international RET mutation consortium. J Inter Med，1995,238:343-346.
10Glover J R, Shorvon P J, Lees W R.Endoscopic ultrasound for localisation of isletcell tumors. Gut，1992,33:108-110.
